Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping

Conditions: Moderate to Severe Asthma Interventions: Biological: Dupilumab; Biological: Benralizumab Sponsors: University of California, San Diego; Mayo Clinic; Yale University; University of Arizona; Harvard University; Brigham and Women ' s Hospital; National Heart, Lung, and Blood Institute (NHLBI) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials